Bone and Body Comp: A Sub Study of the SECOND-LINE Study

NCT01513122 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

210

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV

Interventions

DRUG: Lopinavir / ritonavir
DRUG: 2-3N(t)RTI
DRUG: raltegravir

Sponsor

Kirby Institute